NextPlat Corp. (NASDAQ: NXPL, NXPLW) announced that its wholly owned pharmacy subsidiary, PharmcoRx, plans to introduce automated prescription dispensing kiosks from VendRx at select customer clinics and health care facilities. The kiosks will allow patients to obtain prescribed medications onsite following appointments and consultation with a PharmcoRx pharmacist, reducing the need for separate pharmacy visits. Initial installations are planned for the fourth quarter of 2026, with broader deployment expected throughout 2027. The initiative is designed to improve medication access and adherence while expanding PharmcoRx's prescription services and relationships with health care providers. VendRx reports approximately 80% formulary coverage per deployment and more than 90,000 successful prescription dispenses since inception, with no wrong-medication releases reported through Oct. 19, 2026, according to its internal records.
The move matters because it positions PharmcoRx to address persistent gaps in pharmacy access, particularly in underserved communities where retail pharmacies are scarce. By placing dispensing technology directly in clinics, the program could allow providers to offer prescription dispensing without additional staffing or the cost of building an onsite pharmacy. For NextPlat, the kiosks represent an additional prescription channel that may support expansion through independent clinics and health care providers, potentially driving new revenue streams and deeper partnerships. The company's broader strategy includes leveraging acquisitions and collaborations to help businesses sell goods online, and this initiative aligns with its focus on healthcare and technology solutions. As NextPlat (NASDAQ: NXPL, NXPLW) continues to build out its pharmacy and healthcare data management services through subsidiaries like Progressive Care, the kiosk program could serve as a scalable model for improving medication adherence and access across the United States.
Investors and industry observers can follow further developments through NextPlat's newsroom at https://ibn.fm/NXPL. For a deeper look at the announcement, the full press release is available at https://ibn.fm/dIWEa. BioMedWire, which distributed the announcement, operates as part of the Dynamic Brand Portfolio @ IBN, a network that provides access to wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. These resources are designed to help companies like NextPlat reach a wide audience of investors, influencers, and the general public. The platform's reach and specialized focus on biotechnology and life sciences make it a relevant channel for news in the healthcare technology space. As PharmcoRx moves toward its first kiosk installations, the program's success will depend on clinic adoption and patient uptake, but the early metrics from VendRx suggest a viable path forward. The initiative also reflects a broader trend of integrating automation into pharmacy services to reduce friction and improve outcomes, especially for patients managing chronic conditions. With no wrong-medication releases reported to date, safety remains a key selling point. For NextPlat, the kiosks could enhance its value proposition to health care providers and strengthen its position in the competitive pharmacy services market.
